Overview of Hemorrhagic Stroke Care in the Emergency Unit

  • Natalie Kreitzer
  • Daniel WooEmail author
Part of the Stroke Revisited book series (STROREV)


Spontaneous intracerebral hemorrhage (ICH) is a neurologic emergency. Patients presenting to the emergency department (ED) with ICH must be rapidly diagnosed, managed, and transported to an ICU or operating room. Emergency physicians must be prepared to stabilize and diagnose patients with ICH in a timely fashion and have knowledge about the underlying disease process and the evidence supporting various treatment modalities. In combination with rapid diagnosis, appropriate treatment of elevated blood pressure and coagulopathy, and preparedness for common pitfalls related to ICH, patient outcomes can be substantially improved. ICH occurs without warning, has a high mortality, and leaves many survivors with significant disability. Nevertheless, outcomes have improved over the last several decades due to advances in emergency and critical care. Although once thought of as a uniformly devastating disease, many patients have improved mortality and morbidity following ICH thanks to several recent advances and new studies that have been published. In particular, recent studies pertaining to the management of patients with ICH and concomitant antiplatelet medications, anticoagulation, and hypertension are critical for the practicing emergency physician. This chapter describes the current evidence as it pertains to emergent treatment of ICH.


Emergency Department Practicing Emergency Physician Intracerebral Hemorrhage Intracerebral Haemorrhage (ICH) Novel Oral Anticoagulants (NOACS) 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450–60.CrossRefPubMedGoogle Scholar
  2. 2.
    Van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–76.CrossRefPubMedGoogle Scholar
  3. 3.
    Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.CrossRefPubMedGoogle Scholar
  5. 5.
    Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11:307–14.CrossRefPubMedGoogle Scholar
  8. 8.
    Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387:2605–13.CrossRefPubMedGoogle Scholar
  10. 10.
    Samama MM, Guinet C. Laboratory assessment of new anticoagulants. Clin Chem Lab Med. 2011;49:761–72.CrossRefPubMedGoogle Scholar
  11. 11.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.CrossRefGoogle Scholar
  12. 12.
    Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.CrossRefPubMedGoogle Scholar
  13. 13.
    Berkhemer OA, Majoie CB, Dippel DW. Endovascular therapy for ischemic stroke. N Engl J Med. 2015;372:2363.CrossRefPubMedGoogle Scholar
  14. 14.
    Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30.CrossRefPubMedGoogle Scholar
  15. 15.
    Campbell BC, Mitchell PJ. Endovascular therapy for ischemic stroke. N Engl J Med. 2015;372:2365–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.CrossRefPubMedGoogle Scholar
  17. 17.
    Elmer J, Pallin DJ, Liu S, et al. Prolonged emergency department length of stay is not associated with worse outcomes in patients with intracerebral hemorrhage. Neurocrit Care. 2012;17:334–42.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Jabre P, Combes X, Lapostolle F, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet. 2009;374:293–300.CrossRefPubMedGoogle Scholar
  19. 19.
    Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75:731–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Faigle R, Bahouth MN, Urrutia VC, et al. Racial and socioeconomic disparities in gastrostomy tube placement after intracerebral hemorrhage in the United States. Stroke. 2016;47:964–70.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Sakamoto Y, Koga M, Yamagami H, et al. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke. 2013;44:1846–51.CrossRefPubMedGoogle Scholar
  22. 22.
    Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804–10.CrossRefPubMedGoogle Scholar
  23. 23.
    Koch S, Romano JG, Forteza AM, et al. Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care. 2008;8:316–21.CrossRefPubMedGoogle Scholar
  24. 24.
    Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65.CrossRefPubMedGoogle Scholar
  25. 25.
    Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559–76.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116–21.CrossRefPubMedGoogle Scholar
  27. 27.
    Goldstein JN, Thomas SH, Frontiero V, et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke. 2006;37:151–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Kuramatsu JB, Gerner ST, Schellinger PD, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015;313:824–36.CrossRefPubMedGoogle Scholar
  29. 29.
    Nee R, Doppenschmidt D, Donovan DJ, et al. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. Am J Cardiol. 1999;83:286–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234–43.PubMedGoogle Scholar
  31. 31.
    Levy J, Tanaka K, Dietrich W. Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology. 2008;109:918.CrossRefPubMedGoogle Scholar
  32. 32.
    Dusel CH, Grundmann C, Eich S, et al. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates. Blood Coagul Fibrinolysis. 2004;15:405–11.CrossRefPubMedGoogle Scholar
  33. 33.
    Frontera JA, Gordon E, Zach V, et al. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage. Neurocrit Care. 2014;21:397–406.CrossRefPubMedGoogle Scholar
  34. 34.
    Steiner T, Poli S, Griebe M, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 2016;15:566–73.CrossRefPubMedGoogle Scholar
  35. 35.
    Pollack CV Jr, Reilly PA, Eikelboom J, et al. Idarucizumab for Dabigatran Reversal. N Engl J Med. 2015;373:511–20.CrossRefPubMedGoogle Scholar
  36. 36.
    Garcia DA, Baglin TP, Weitz JI, et al. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians. Evidence-based clinical practice guidelines. Chest. 2012;141:e24S–43S.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Khoo TL, Weatherburn C, Kershaw G, et al. The use of FEIBA(R) in the correction of coagulation abnormalities induced by dabigatran. Int J Lab Hematol. 2013;35:222–4.CrossRefPubMedGoogle Scholar
  38. 38.
    Yates SW. Interrupting anticoagulation in patients with nonvalvular atrial fibrillation. P T. 2014;39:858–80.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Connolly SJ, Milling TJ Jr, Eikelboom JW, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375:1131–41.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Perzborn E, Heitmeier S, Laux V, et al. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro. Thromb Res. 2014;133:671–81.CrossRefPubMedGoogle Scholar
  41. 41.
    Escolar G, Fernandez-Gallego V, Arellano-Rodrigo E, et al. Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human blood. PLoS One. 2013;8:e78696.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Zhou W, Schwarting S, Illanes S, et al. Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran. Stroke. 2011;42:3594–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Godier A, Miclot A, Le Bonniec B, et al. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model. Anesthesiology. 2012;116:94–102.CrossRefPubMedGoogle Scholar
  44. 44.
    Fukuda T, Honda Y, Kamisato C, et al. Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents. Thromb Haemost. 2012;107:253–9.CrossRefPubMedGoogle Scholar
  45. 45.
    Naidech AM, Maas MB, Levasseur-Franklin KE, et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke. 2014;45:2451–3.CrossRefPubMedGoogle Scholar
  46. 46.
    Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.CrossRefPubMedGoogle Scholar
  47. 47.
    Zehtabchi S, Abdel Baki SG, Falzon L, et al. Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis. Am J Emerg Med. 2014;32:1503–9.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Berger AR, Lipton RB, Lesser ML, et al. Early seizures following intracerebral hemorrhage: implications for therapy. Neurology. 1988;38:1363–5.CrossRefPubMedGoogle Scholar
  49. 49.
    Messe SR, Sansing LH, Cucchiara BL, et al. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11:38–44.CrossRefPubMedGoogle Scholar
  50. 50.
    Sheth KN, Martini SR, Moomaw CJ, et al. Prophylactic antiepileptic drug use and outcome in the ethnic/racial variations of intracerebral hemorrhage study. Stroke. 2015;46:3532–5.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Sykora M, Steinmacher S, Steiner T, et al. Association of intracranial pressure with outcome in comatose patients with intracerebral hemorrhage. J Neurol Sci. 2014;342:141–5.CrossRefPubMedGoogle Scholar
  52. 52.
    Schulz-Stubner S, Thiex R. Raising the head-of-bed by 30 degrees reduces ICP and improves CPP without compromising cardiac output in euvolemic patients with traumatic brain injury and subarachnoid haemorrhage: a practice audit. Eur J Anaesthesiol. 2006;23:177–80.CrossRefPubMedGoogle Scholar
  53. 53.
    Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery. 1999;44:1055–63.CrossRefPubMedGoogle Scholar
  54. 54.
    Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.CrossRefPubMedGoogle Scholar
  55. 55.
    Mendelow AD, Gregson BA, Rowan EN, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382:397–408.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Da Pian R, Bazzan A, Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res. 1984;6:145–51.CrossRefPubMedGoogle Scholar
  57. 57.
    Morgenstern LB, Zahuranec DB, Sanchez BN, et al. Full medical support for intracerebral hemorrhage. Neurology. 2015;84:1739–44.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.CrossRefPubMedGoogle Scholar
  59. 59.
    Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001–23.CrossRefPubMedGoogle Scholar
  60. 60.
    Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–81.CrossRefPubMedGoogle Scholar
  61. 61.
    Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635–40.CrossRefPubMedGoogle Scholar
  62. 62.
    Zahuranec DB, Brown DL, Lisabeth LD, et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology. 2007;68:1651–7.CrossRefPubMedGoogle Scholar
  63. 63.
    Fan JS, Huang HH, Chen YC, et al. Emergency department do-not-resuscitate order in patients with spontaneous intracerebral hemorrhage. Am J Emerg Med. 2017;35:1850–4.CrossRefPubMedGoogle Scholar
  64. 64.
    Hanley DF, Awad IA, Vespa PM, et al. Hemorrhagic stroke: introduction. Stroke. 2013;44:S65–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2018

Authors and Affiliations

  1. 1.Department of Emergency Medicine and Division of Neurocritical CareUniversity of CincinnatiCincinnatiUSA
  2. 2.Department of Neurology and Rehabilitation MedicineUniversity of CincinnatiCincinnatiUSA

Personalised recommendations